College of Science & Engineering, National University of Ireland, H91 TK33 Galway, Ireland.
College of Science, Atlantic Technological University, F91 YW50 Sligo, Ireland.
Int J Environ Res Public Health. 2022 Aug 3;19(15):9534. doi: 10.3390/ijerph19159534.
Assisted Human Reproduction (AHR) treatment is unregulated in Ireland, although it is practised there. Within Europe, Ireland is one of the only European countries without any form of AHR-specific regulation. This study aims to investigate the experiences and viewpoints of Irish women undergoing AHR treatments and establish if the lack of legislation is affecting these experiences. A quantitative survey was carried out on women undergoing AHR treatment in Irish clinics. Patients highlighted a lack of information in terms of end-to-end care and poor information around treatments and success rates. Key issues highlighted included unanticipated high treatment costs and add-on treatment costs, lack of financial support from the government, no redress process in the event of dissatisfaction, and generally an overall feeling of a lack of support both from the AHR clinics and the Irish government. This study offers a real-time view of the Irish AHR system from the patient's experience of AHR and under the lens of the lack of a legislative system. In early 2022, the Irish government announced that it would adopt its bill around AHR treatment and that subsidies for AHR treatment are to come into effect, which will alleviate some financial pressures on patients. Further studies of the legislation carried out post implementation will provide more information about the impact of having a legislated AHR process on the patients.
辅助生殖治疗(AHR)在爱尔兰不受监管,尽管那里有这种治疗。在欧洲,爱尔兰是唯一一个没有任何形式的 AHR 特定法规的欧洲国家。本研究旨在调查爱尔兰接受 AHR 治疗的女性的经验和观点,并确定缺乏立法是否会影响这些经验。在爱尔兰诊所接受 AHR 治疗的女性进行了一项定量调查。患者强调,在端到端护理方面缺乏信息,并且对治疗和成功率的信息很差。突出的关键问题包括治疗费用意外高昂和附加治疗费用、政府缺乏财政支持、对不满没有补救程序,以及普遍对 AHR 诊所和爱尔兰政府缺乏支持的感觉。本研究从患者接受 AHR 的体验以及缺乏立法制度的角度,实时观察爱尔兰的 AHR 系统。2022 年初,爱尔兰政府宣布将通过其关于 AHR 治疗的法案,并将实施 AHR 治疗补贴,这将减轻患者的一些经济压力。实施后对立法进行的进一步研究将提供更多关于立法 AHR 程序对患者的影响的信息。